Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne Huber

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Digestive Diseases (Basel, Switzerland)|July 5, 2017
Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with SorafenibChristian Labenz, Vera Prenosil, Sandra Koch, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 12, 2021
Health-related quality of life in patients with autoimmune hepatitisMaurice Michel, Francesca Spinelli, Annette Grambihler, et al.
Hepatology Communications|February 5, 2022
Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population-Based Study in GermanyYvonne Huber, Andreas Schulz, Irene Schmidtmann, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept studyAngelo Armandi, Helena Bespaljko, Alexander Mang, et al.
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Journal of Clinical Medicine|August 12, 2022
Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4Katharina John, Martin Franck, Sherin Al Aoua, et al.
European Journal of Internal Medicine|September 3, 2020
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosisChristian Labenz, Michael Nagel, Gerrit Toenges, et al.
Alimentary Pharmacology & Therapeutics|October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in GermanyChristian Labenz, Yvonne Huber, Eva Kalliga, et al.
Journal of Hepatology|July 13, 2016
Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factorsNadine Gehrke, Marcus A Wörns, Yvonne Huber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic InflammationYvonne Huber, Marie Boyle, Kate Hallsworth, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Digestive Diseases (Basel, Switzerland)|July 5, 2017
Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with SorafenibChristian Labenz, Vera Prenosil, Sandra Koch, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 12, 2021
Health-related quality of life in patients with autoimmune hepatitisMaurice Michel, Francesca Spinelli, Annette Grambihler, et al.
Hepatology Communications|February 5, 2022
Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population-Based Study in GermanyYvonne Huber, Andreas Schulz, Irene Schmidtmann, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept studyAngelo Armandi, Helena Bespaljko, Alexander Mang, et al.
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Journal of Clinical Medicine|August 12, 2022
Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4Katharina John, Martin Franck, Sherin Al Aoua, et al.
European Journal of Internal Medicine|September 3, 2020
Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosisChristian Labenz, Michael Nagel, Gerrit Toenges, et al.
Alimentary Pharmacology & Therapeutics|October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in GermanyChristian Labenz, Yvonne Huber, Eva Kalliga, et al.
Journal of Hepatology|July 13, 2016
Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factorsNadine Gehrke, Marcus A Wörns, Yvonne Huber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2018
Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic InflammationYvonne Huber, Marie Boyle, Kate Hallsworth, et al.
Pageof 5